Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced its participation in the first-ever, all-digital CES 2021, beginning today and running through Jan. 14. Since the initial outbreak of COVID-19 a year ago, healthcare has experienced a rapid transformation and acceleration of digital health technologies. During CES 2021, Philips will highlight a unique hybrid view of advanced technology solutions fast-tracking healthcare, moving outside the four walls of the hospital and into the home.
Telehealth, including tele-dentistry, virtual care and remote monitoring have played significant roles during the pandemic and will continue to play central roles in health and well-being post COVID-19 and beyond. At this year’s CES 2021, Philips has created an interactive virtual healthy neighborhood that visitors can self-navigate. The immersive experience brings three core storylines to life, demonstrating how Philips digital health technology is supporting consumers and patients alike during COVID-19. From first-time expecting parents, to at-risk people living with chronic – and often related – conditions like cardiac disease, diabetes, or sleep apnea, to those who want to improve their oral health, Philips will spotlight end-to-end solutions to help safely evaluate and monitor people to better manage healthcare at home.
We have also witnessed the reinvention of our homes as a core element of the healthcare pathway, with telehealth, virtual and remote care technologies as the key drivers for change during COVID-19. And these changes are here to stay.
Deeptha Khanna
Chief Business Leader, Personal Health, Philips
Pregnant mothers are a vulnerable population and may have several concerns and anxieties about the impact of COVID-19 infection on pregnancy [1]. Philips COVID-19 Fetal and Maternal solution within the Avalon product family, including patch and digital twin of the fetal monitor, allows clinicians to monitor vital signs of both mom and baby from home or an isolation room to help reduce unnecessary physical interactions between clinicians and patients.
In the belief that parents should be able to make decisions based on the best possible evidence, Philips and GSK have teamed up to equip Philips’ Pregnancy+ and Baby+ apps with comprehensive and reliable information about vaccine preventable diseases and the vaccines that are available. The apps, reaching a combined total of nearly 2 million parents worldwide every day, provide articles and videos about the importance of vaccination, together with a vaccination hub to help parents access comprehensive and reliable information to support conversations with their healthcare professionals, such as which vaccines are relevant and when they need to be administered. Parents are also invited to participate in on-line research to help to better understand their views on different vaccinations.
For people living with health conditions like diabetes or cardiac disease, Philips will highlight its recently introduced biosensor-based solutions for remote monitoring of at-risk chronic disease patients as they transition from the hospital into the home. Philips will also spotlight its end-to-end, clinically proven sleep solutions, designed to help address chronic sleep conditions like sleep apnea from discovery, to diagnosis, through treatment and adherence – even from the home. Being showcased for the first time at CES is the Philips Mask Selector, the first and only clinically validated, 3D facial scanning solution that helps providers fit 9 out of 10 patients with the right mask from the start [2]. The proprietary Mask Selector algorithm offers a novel solution in the shift toward digitization of health care, helping to improve business efficiencies by reducing costs associated with fitting time and mask waste.
On Dec. 15, the Consumer Technology Association (CTA)® announced the CES® 2021 Innovation Awards honorees, including those products recognized as Best of Innovation. Honorees are recognized for outstanding products, upcoming trends and how companies are using technology to change lives for the better. Philips been named a CES® 2021 Innovation Awards honoree recognized for multiple technology solutions across personal and professional health including the Philips Patient Monitoring Kit; the Philips Wearable Biosensor; the Philips Mask Selector; the Philips Sonicare Prestige 9900; and Philips Teledentistry.
Visit the Philips exhibitor showcase at the all-digital CES 2021 to learn more and follow @PhilipsLiveFrom for live updates throughout the event. While the Philips virtual healthy neighborhood experience is built for CES, the platform will be live throughout the year to continue to demonstrate both Personal Health and Connected Care technology solutions supporting consumer health.
[1] Covid-19 related anxiety and concerns expressed by pregnant and post-partum women – a survey among obstetricians (nih.gov): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445074/.
[2] 2019 Philips sponsored patient preference trial (n=310). Patients scanned using Mask Selector (n=153) vs. traditional fitting methods (n=157).
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Philips Global Press Office
Tel.: +1 978-221-8919
Philips Global Press Office
Tel.: +31 6 20740318
February 26, 2021
